These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11122905)

  • 21. Overview of depression and psychosis in Alzheimer's disease.
    Wragg RE; Jeste DV
    Am J Psychiatry; 1989 May; 146(5):577-87. PubMed ID: 2653053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychiatric aspects of Parkinson's disease.
    Aarsland D; Karlsen K
    Curr Psychiatry Rep; 1999 Oct; 1(1):61-8. PubMed ID: 11122906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral correlates of psychotic symptoms in Alzheimer's disease.
    Mega MS; Lee L; Dinov ID; Mishkin F; Toga AW; Cummings JL
    J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):167-71. PubMed ID: 10896687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using risperidone for Alzheimer's dementia-associated psychosis.
    McNeal KM; Meyer RP; Lukacs K; Senseney A; Mintzer J
    Expert Opin Pharmacother; 2008 Oct; 9(14):2537-43. PubMed ID: 18778191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addressing the Alzheimer's disease crisis through better understanding, treatment, and eventual prevention of associated neuropsychiatric syndromes.
    Lyketsos CG; Miller DS;
    Alzheimers Dement; 2012 Jan; 8(1):60-4. PubMed ID: 22265590
    [No Abstract]   [Full Text] [Related]  

  • 26. Psychosocial or clinico-demographic factors related to neuropsychiatric symptoms in patients with Alzheimer's disease needing interventional treatment: analysis of the CATIE-AD study.
    Nagata T; Nakajima S; Shinagawa S; Plitman E; Graff-Guerrero A; Mimura M; Nakayama K
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):1264-1271. PubMed ID: 27714849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neurobiology of neuropsychiatric syndromes in dementia.
    Meeks TW; Ropacki SA; Jeste DV
    Curr Opin Psychiatry; 2006 Nov; 19(6):581-6. PubMed ID: 17012935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influences of psychotic symptoms on the activities of daily living of individuals with Alzheimer disease: a longitudinal analysis.
    Tran M; Bédard M; Dubois S; Weaver B; Molloy DW
    Aging Ment Health; 2013; 17(6):738-47. PubMed ID: 23425341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychosis and Clinical Outcomes in Alzheimer Disease: A Longitudinal Study.
    Connors MH; Ames D; Woodward M; Brodaty H
    Am J Geriatr Psychiatry; 2018 Mar; 26(3):304-313. PubMed ID: 29174998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurobehaviors and psychotic symptoms in Alzheimer's disease.
    Paulsen JS; Ready RE; Stout JC; Salmon DP; Thal LJ; Grant I; Jeste DV
    J Int Neuropsychol Soc; 2000 Nov; 6(7):815-20. PubMed ID: 11105471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?
    Rosenberg PB; Nowrangi MA; Lyketsos CG
    Mol Aspects Med; 2015; 43-44():25-37. PubMed ID: 26049034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Depression in Alzheimer's disease].
    Ponomareva EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(2):4-11. PubMed ID: 18427497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral and neuropsychiatric outcomes in Alzheimer's disease.
    Cummings JL
    CNS Spectr; 2005 Nov; 10(11 Suppl 18):22-5. PubMed ID: 16273027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003.
    Ropacki SA; Jeste DV
    Am J Psychiatry; 2005 Nov; 162(11):2022-30. PubMed ID: 16263838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiety, depression and psychosis in vascular dementia: prevalence and associations.
    Ballard C; Neill D; O'Brien J; McKeith IG; Ince P; Perry R
    J Affect Disord; 2000 Aug; 59(2):97-106. PubMed ID: 10837878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Factors that modify the natural course of Alzheimer's disease].
    López OL; Becker JT
    Rev Neurol; 2003 Jul 16-31; 37(2):149-55. PubMed ID: 12938075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design.
    Devanand DP; Strickler JG; Huey ED; Crocco E; Forester BP; Husain MM; Vahia IV; Andrews H; Wall MM; Pelton GH
    Contemp Clin Trials; 2018 Aug; 71():33-39. PubMed ID: 29859917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mental-behavioral disorders in Alzheimer's disease].
    Touchon J; Portet-Tarodo F; Ritchie K
    Rev Prat; 1998 Nov; 48(17):1898-905. PubMed ID: 9854392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer disease.
    Devanand DP
    Alzheimer Dis Assoc Disord; 1999 Nov; 13 Suppl 2():S3-8. PubMed ID: 10622673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia.
    Van der Mussele S; Le Bastard N; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Aging Ment Health; 2015; 19(3):247-57. PubMed ID: 24962058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.